| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | 0.096 | 0.002 |
| mRNA | JQ-1:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | 0.17 | 0.003 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.094 | 0.003 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |